Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysis

PURPOSE: The availability of immune checkpoint inhibitors has deeply changed the therapeutic scenario of patients with advanced non-small cell lung cancer (NSCLC). Up until now, chemotherapy still represents the first-line treatment for patients with advanced NSCLC not harbouring genetic mutations o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ecancermedicalscience
Main Authors: Gebbia, Vittorio, Aiello, Marco Maria, Banna, Giuseppe, Blanco, Giusi, Blasi, Livio, Borsellino, Nicolò, Giuffrida, Dario, Mauro, Mario Lo, Mancuso, Gianfranco, Piazza, Dario, Savio, Giuseppina, Parra, Hector Soto, Valerio, Maria Rosaria, Verderame, Francesco, Vigneri, Paolo
Formato: Artigo
Idioma:Inglês
Publicado em: Cancer Intelligence 2020
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7581333/
https://ncbi.nlm.nih.gov/pubmed/33144881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2020.1113
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados